Top

Intensive Care Medicine

Published in:

01-11-2020 | SARS-CoV-2 | Letter

The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19

Authors: Yuman Li, He Li, Meng Li, Li Zhang, Mingxing Xie

Published in: Intensive Care Medicine | Issue 11/2020

Excerpt

Dear Editor, …

Available only for authorised users

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46(5):846–848. https://doi.org/10.1007/s00134-020-05991-xCrossRefPubMed

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128(16):1810–1852. https://doi.org/10.1161/CIR.0b013e31829e8807CrossRefPubMed

Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani FD, Raval AN, Ward C (2018) American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia. Evaluation and Management of Right-Sided Heart Failure: a Scientific Statement From the American Heart Association. Circulation 137(20):578–622. https://doi.org/10.1161/CIR.0000000000000560CrossRef

Leisman DE, Deutschman CS, Legrand M (2020) Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med 46(6):1105–1108. https://doi.org/10.1007/s00134-020-06059-6CrossRefPubMedPubMedCentral

Yishay S, Yael L, Philippe T, Ariel B, Aviram H, Ilan M, Amir GO, Ehud R, Guy B, Yogev P, Yaron A, Yan T (2020) The spectrum of cardiac manifestations in Coronavirus Disease 2019 (COVID-19): a systematic echocardiographic study. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.120.047971CrossRef

Title: The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19
Authors: Yuman Li
He Li
Meng Li
Li Zhang
Mingxing Xie
Publication date: 01-11-2020
Publisher: Springer Berlin Heidelberg
Keywords: SARS-CoV-2
Heart Failure
Acute Respiratory Distress-Syndrome
COVID-19
Published in: Intensive Care Medicine / Issue 11/2020
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-020-06205-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2020

Less is more: critically ill status is not a carte blanche for unlimited antibiotic use

Transpulmonary driving pressure, without esophageal pressure measurements, instead of airway driving pressure

Hospital mortality in mechanically ventilated COVID-19 patients in Mexico

Access to intensive care in 14 European countries: a spatial analysis of intensive care need and capacity in the light of COVID-19

Left ventricular diastolic dysfunction as a predictor of weaning failure from mechanical ventilation. Author’s reply

ECMO for severe ARDS: systematic review and individual patient data meta-analysis